Tumori Journal

Scope & Guideline

Leading the Way in Cancer Understanding and Care.

Introduction

Delve into the academic richness of Tumori Journal with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0300-8916
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 1946 to 2024
AbbreviationTUMORI J / Tumori J.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The Tumori Journal focuses on a wide array of cancer research, emphasizing the interplay between clinical practice, innovative therapies, and the biological mechanisms underlying cancer. The journal aims to disseminate knowledge that bridges the gap between laboratory findings and clinical applications, making it a vital resource for oncologists, researchers, and healthcare professionals.
  1. Clinical Oncology and Treatment Advances:
    The journal publishes studies on the latest clinical practices in oncology, including novel treatment protocols, drug efficacy, and patient management strategies across various cancer types.
  2. Epidemiology and Public Health:
    Research on cancer incidence, mortality rates, and public health strategies to combat cancer is a significant focus, providing insights into trends and health policies.
  3. Biomarkers and Precision Medicine:
    The exploration of predictive biomarkers and their application in personalized medicine is a core area, highlighting how genetic and molecular profiling can influence treatment decisions.
  4. Radiotherapy and Surgical Techniques:
    Innovations in radiotherapy techniques and surgical interventions are frequently discussed, focusing on their impact on treatment outcomes and patient safety.
  5. Pediatric Oncology:
    A dedicated section for pediatric cancer research, addressing unique challenges and advancements in treating childhood cancers.
  6. Psychosocial Aspects and Quality of Life:
    The journal emphasizes the importance of psychosocial support for cancer patients, including quality of life assessments and the impact of cancer on mental health.
Recent trends in the Tumori Journal reveal a dynamic shift towards emerging themes that reflect the evolving landscape of cancer research. These themes highlight the journal's commitment to addressing contemporary challenges and advancements in oncology.
  1. Immunotherapy and Combination Treatments:
    There is a notable increase in research dedicated to immunotherapy, particularly studies examining combination therapies that enhance treatment efficacy and patient response.
  2. Digital Health and Telemedicine in Oncology:
    The COVID-19 pandemic has accelerated interest in digital health solutions, with a growing number of papers exploring telemedicine applications in cancer care and patient management.
  3. Health Equity and Cancer Disparities:
    Emerging research addressing health disparities among different populations is gaining traction, focusing on social determinants of health and equitable access to cancer care.
  4. AI and Machine Learning in Oncology:
    The application of artificial intelligence and machine learning techniques in cancer diagnosis, treatment planning, and patient monitoring is an emerging theme, reflecting the integration of technology in healthcare.
  5. Patient-Centered Care and Quality of Life Research:
    There is an increasing emphasis on patient-reported outcomes and quality of life studies, underscoring the importance of addressing the holistic needs of cancer patients.

Declining or Waning

As the field of oncology evolves, certain themes have begun to recede in prominence within the Tumori Journal's publications. These declining areas may reflect shifts in research focus or advancements in technology that render previous topics less relevant.
  1. Traditional Chemotherapy Protocols:
    There is a noticeable decline in papers focusing on conventional chemotherapy regimens as newer targeted therapies and immunotherapies gain traction in the field.
  2. General Cancer Screening Guidelines:
    Research articles that discuss broad cancer screening guidelines have decreased, possibly overshadowed by more specific studies that evaluate targeted screening strategies based on genetic predispositions.
  3. Basic Science and Tumor Biology:
    While foundational research remains important, there has been a shift toward translational research and clinical applications, leading to fewer publications solely focused on basic tumor biology.
  4. End-of-Life Care Practices:
    Although important, there appears to be a waning interest in traditional end-of-life care studies, which may be transitioning towards more comprehensive palliative care approaches that integrate multidisciplinary care strategies.
  5. Epidemiological Studies Without Regional Focus:
    Epidemiological studies that do not analyze specific regional data or trends are becoming less common, as researchers increasingly focus on localized studies that provide actionable insights into specific populations.

Similar Journals

Radiation Oncology

Advancing cancer care through innovative radiotherapy insights.
Publisher: BMCISSN: Frequency: 1 issue/year

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

Oncology Reviews

Empowering Oncology Insights for a Healthier Tomorrow
Publisher: FRONTIERS MEDIA SAISSN: 1970-5557Frequency: 2 issues/year

Oncology Reviews, founded in 2007 and published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to advancing knowledge in the field of oncology and cancer research. With an Impact Factor reflecting its robust engagement in scholarly discourse, this journal maintains a prestigious standing, earning a Q2 ranking in Oncology and a Q3 ranking in Cancer Research as of 2023. Notably, it is indexed in Scopus, where it ranks #118 in Oncology and #98 in Cancer Research, highlighting its global reach and significance. The journal's open-access policy, in effect since 2012, ensures that high-quality research is accessible to all, fostering collaboration and wellness improvements worldwide. This commitment to accessibility and dissemination of pivotal research makes Oncology Reviews an essential resource for researchers, healthcare professionals, and students eager to contribute to and stay abreast of the latest innovations in cancer treatment and research.

ONCOLOGY

Leading the charge against cancer with rigorous scholarship.
Publisher: KARGERISSN: 0030-2414Frequency: 12 issues/year

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

JNCI-Journal of the National Cancer Institute

Driving excellence in cancer research since 1940.
Publisher: OXFORD UNIV PRESS INCISSN: 0027-8874Frequency: 12 issues/year

JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.

BREAST CANCER RESEARCH AND TREATMENT

Innovating Research, Transforming Treatment
Publisher: SPRINGERISSN: 0167-6806Frequency: 18 issues/year

Breast Cancer Research and Treatment, published by Springer, stands as a pivotal journal within the domains of Cancer Research and Oncology, exemplified by its impressive Q2 and Q1 quartile rankings, respectively, in the 2023 category rankings. Since its inception in 1981, this journal has provided a vital platform for disseminating cutting-edge research focused on all aspects of breast cancer, ranging from molecular biology to treatment strategies. With an ISSN of 0167-6806 and E-ISSN of 1573-7217, it captures a broad audience of researchers, clinicians, and students dedicated to improving patient outcomes. The journal emphasizes high-quality, peer-reviewed studies that pave the way for advancements in therapy and direct novel insights into oncological practices. By maintaining a strong ranking in Scopus with percentile placements of 74th in Oncology and 61st in Cancer Research, Brest Cancer Research and Treatment continues to foster innovation and collaboration in the fight against breast cancer.

Cancers

Exploring the frontiers of cancer biology and therapy.
Publisher: MDPIISSN: Frequency: 24 issues/year

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

INDIAN JOURNAL OF CANCER

Advancing Oncology Knowledge for a Healthier Tomorrow
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0019-509XFrequency: 4 issues/year

INDIAN JOURNAL OF CANCER, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of oncology, providing dedicated insight into cancer research and its clinical applications since its inception in 1965. With an ISSN of 0019-509X and an E-ISSN of 1998-4774, this esteemed journal facilitates the dissemination of knowledge related to cancer prevention, diagnosis, and treatment strategies within the Indian context and beyond. Although classified within the Q3 quartile of oncology journals and ranked #292 out of 404 in its category in the Scopus database, the INDIAN JOURNAL OF CANCER continues to play a vital role in advancing the dialogue around cancer management. This journal is particularly significant for researchers, professionals, and students intent on contributing to the evolving landscape of oncology, offering a platform for sharing innovative findings and fostering collaboration among the academic community. Located in Mumbai, India, the journal's commitment to impactful research is reflected in its ongoing efforts to bridge gaps in cancer knowledge and address the unique challenges faced within the region and globally.

Cancer Management and Research

Illuminating the complexities of oncology for better health.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Clinical Genitourinary Cancer

Transforming insights into clinical practice.
Publisher: CIG MEDIA GROUP, LPISSN: 1558-7673Frequency: 6 issues/year

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Oncology in Clinical Practice

Bridging Clinical Insights and Cancer Research
Publisher: VIA MEDICAISSN: 2450-1654Frequency: 6 issues/year

Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.